[1] Chen SM,Dumler JS,Bakken JS,et al. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease[J]. J Clin Microbiol, 1994, 32(3):589-595. [2] Zhang LJ,Liu Y,Ni DX,et al. Nosocomial transmission of human granulocytic anaplasmosis in China[J]. JAMA, 2008, 300(19):2263-2270. [3] Lin MQ, Kikuchi T, Brewer HM, et al. Global proteomic analysis of two tick-borne emerging zoonotic agents:Anaplasma phagocytophilum and Ehrlichia chaffeensis[J]. Front Microbiol, 2011, 2:24. [4] Dunning Hotopp JC,Lin MQ,Madupu R,et al. Comparative genomics of emerging human ehrlichiosis agents[J]. PLoS Genet, 2006, 2(2):e21. [5] Lin Q, Rikihisa Y,Ohashi N,et al. Mechanisms of variable p44 expression by Anaplasma phagocytophilum[J]. Infect Immun, 2003, 71(10):5650-5661. [6] Ohashi N, Gaowa, Wuritu, et al. Human granulocytic anaplasmosis, Japan[J]. Emerg Infect Dis, 2013, 19(2):289-292. [7] Jiao XY,Fan ZC,Li YZ,et al. Clinical and laboratory features parameters of human granulocytic anaplasmosis(HGA) in patients admitted to hospital in Guangdong province, China[J]. Trop Doct, 2015, 45(4):209-213. [8] Wang Y,Chen CF,Zhang LJ. Molecular characterization of Msp2/P44 of Anaplasma phagocytophilum isolated from infected patients and Haemaphysalis longicornis in Laizhou Bay, Shandong province, China[J]. PLoS One, 2013, 8(10):e78189. [9] Hao Q, Geng Z, Hou XX, et al. Seroepidemiological investigation of lyme disease and human granulocytic anaplasmosis among people living in forest areas of eight provinces in China[J]. Biomed Environ Sci, 2013, 26(3):185-189. [10] Rikihisa Y. Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum[J]. Clin Microbiol Rev, 2011, 24(3):469-489. |